SKI Market

Indian Indices

Sensex

82,814.71 316.57
( 0.38%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

62.6776943

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

57.2

2891.14

EPS(TTM)

Face Value()

Div & Yield %

5.04

0.03

Back

Sejal Glass reports standalone net loss of Rs 0.65 crore in the September 2025 quarter

Oct 20,2025

Net loss of Sejal Glass reported to Rs 0.65 crore in the quarter ended September 2025 as against net profit of Rs 0.03 crore during the previous quarter ended September 2024. Sales rose 85.09% to Rs 29.80 crore in the quarter ended September 2025 as against Rs 16.10 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	29.80	16.10	85
OPM %	1.95	7.89	-
PBDT	1.43	0.31	361
PBT	-0.65	0.03	PL
NP	-0.65	0.03	PL

82,814.71 316.57 ( 0.38%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)